郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价UR-60427, a novel H4 receptor-inverse agonist that shows good efficacy in a rat asthma model.

期刊：Inflammation research : official journal of the European Histamine Research Society ... [et al.]发表年份：2010作者：J Alfón; N Ardanaz; B Gil-Torregrosa; A Fernández; D Balsa; E Carceller; Ll Gómez; M Merlos; J Cortijo; E Morcillo; X Bartrolí
阅读更多 →

药效评价SLC19A1 pharmacogenomics summary.

期刊：Pharmacogenetics and genomics发表年份：2010作者：Sook Wah Yee; Li Gong; Ilaria Badagnani; Kathleen M Giacomini; Teri E Klein; Russ B Altman
阅读更多 →

药效评价Process monitoring with disposable chemical sensors fit in the framework of process analysis technology (PAT) for innovative pharmaceutical development and quality assurance.

期刊：Chimia发表年份：2010作者：Stefan Spichiger; Ursula E Spichiger-Keller
阅读更多 →

药效评价Combining independent drug classes into superior, synergistically acting hybrid molecules.

期刊：Angewandte Chemie (International ed. in English)发表年份：2010作者：Andreas Müller-Schiffmann; Julia März-Berberich; Aksana Andreyeva; Raik Rönicke; Dirk Bartnik; Oleksandr Brener; Janine Kutzsche; Anselm H C Horn; Marco Hellmert; Jolanta Polkowska; Kurt Gottmann; Klaus G Reymann; S Aileen Funke; Luitgart Nagel-Stege
阅读更多 →